121 211

Cited 53 times in

Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF

Authors
 Song-Nan Zhang  ;  Il-Kyu Choi  ;  Jing-Hua Huang  ;  Ji-Young Yoo  ;  Kyung-Ju Choi  ;  Chae-Ok Yun 
Citation
 MOLECULAR THERAPY, Vol.19(8) : 1558-1568, 2011 
Journal Title
 MOLECULAR THERAPY 
ISSN
 1525-0016 
Issue Date
2011
MeSH
Adenoviridae/genetics* ; Animals ; CD4-Positive T-Lymphocytes/immunology ; Cancer Vaccines/genetics ; Cancer Vaccines/immunology ; Cancer Vaccines/therapeutic use ; Cell Line, Tumor ; Chemokine CCL21/biosynthesis ; Combined Modality Therapy/methods ; Dendritic Cells/immunology* ; Dendritic Cells/metabolism ; Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage ; Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis* ; Granulocyte-Macrophage Colony-Stimulating Factor/genetics ; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use ; Interleukin-12/administration & dosage ; Interleukin-12/biosynthesis* ; Interleukin-12/genetics ; Interleukin-12/therapeutic use ; Interleukin-2 Receptor alpha Subunit/biosynthesis ; Lymph Nodes/immunology ; Melanoma/therapy* ; Mice ; Mice, Inbred C57BL ; Oncolytic Viruses/genetics ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism ; Vaccination ; Vaccines ; Vascular Endothelial Growth Factor A/biosynthesis
Abstract
Dendritic cell (DC)-based vaccination is a promising strategy for cancer immunotherapy. However, clinical trials have indicated that immunosuppressive microenvironments induced by tumors profoundly suppress antitumor immunity and inhibit vaccine efficacy, resulting in insufficient reduction of tumor burdens. To overcome these obstacles and enhance the efficiency of DC vaccination, we generated interleukin (IL)-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-coexpressing oncolytic adenovirus (Ad-ΔB7/IL12/GMCSF) as suitable therapeutic adjuvant to eliminate immune suppression and promote DC function. By treating tumors with Ad-ΔB7/IL12/GMCSF prior to DC vaccination, DCs elicited greater antitumor effects than in response to either treatment alone. DC migration to draining lymph nodes (DLNs) dramatically increased in mice treated with the combination therapy. This result was associated with upregulation of CC-chemokine ligand 21 (CCL21(+)) lymphatics in tumors treated with Ad-ΔB7/IL12/GMCSF. Moreover, the proportion of CD4(+)CD25(+) T-cells and vascular endothelial growth factor (VEGF) expression was decreased in mice treated with the combination therapy. Furthermore, combination therapy using immature DCs also showed effective antitumor effects when combined with Ad-ΔB7/IL12/GMCSF. The combination therapy had a remarkable therapeutic efficacy on large tumors. Taken together, oncolytic adenovirus coexpressing IL-12 and GM-CSF in combination with DC vaccination has synergistic antitumor effects and can act as a potent adjuvant for promoting and optimizing DC vaccination.
Files in This Item:
T201102646.pdf Download
DOI
10.1038/mt.2011.29
Appears in Collections:
1. College of Medicine (의과대학) > Medical Research Center (임상의학연구센터) > 1. Journal Papers
Yonsei Authors
Yoo, Ji Yeong(유지영)
Choi, Kyung Ju(최경주)
Choi, Il Kyu(최일규)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/93595
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse